View of HYPERLIPIDEMIA-SPECIFIC BIOMARKERS WOULD IMPROVE CLINICAL DIAGNOSIS AND THERAPEUTIC TREATMENT AT EARLY DISEASE STAGES.

Return to Article Details HYPERLIPIDEMIA-SPECIFIC BIOMARKERS WOULD IMPROVE CLINICAL DIAGNOSIS AND THERAPEUTIC TREATMENT AT EARLY DISEASE STAGES. Download Download PDF